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Verner et al. (2013) recently questioned 
whether the association between cord levels 
of PCB-153 (poly chlorinated biphenyl-153) 
and birth weight reported in our recent meta-
analysis (Govarts et al. 2012) might be attrib-
utable to the influence of gestational weight 
gain (GWG), a factor that may be related 
to both PCB-153 concentrations and birth 
weight. By using simulated data in a physio-
logically based pharmaco kinetic (PBPK) 
model, Verner et al. (2013) concluded that 
The association between prenatal levels of PCBs 
and birth weight may be strongly confounded by 
the effect of [GWG] on both blood PCB levels 
and birth weight. 
In our recently published meta-analysis 
(Govarts et al. 2012), the influence of 
weight gain was considered only in a sensi-
tivity analy sis because we did not have this 
information from many cohorts at that time. 
Since the publication of that article, we 
have obtained more individual-level data on 
GWG for a number of the cohorts, allowing 
us to repeat these analyses to further assess 
such influence. 
Seven of the 12 birth cohorts that 
partici pated in our previous meta-analysis 
(Govarts et al. 2012) had data on GWG 
available, for a total of 4,473 mother–
child pairs. GWG data from 3 cohorts was 
extracted from pre natal records, whereas 
for the other cohorts the classification was 
based on mother’s recall. In most cohorts, 
weight in late pregnancy was obtained at 
birth or at some weeks before delivery, but 
in two cohorts these data were obtained 
some years after birth. In two cohorts, both 
measured and self-reported data on mother’s 
weight was available, and an excellent cor-
relation was observed (Spearman r = 0.95; 
p < 0.001). In the present reanalysis of the 
data, we also estimated the changes in fat 
mass (FM) as a function of GWG (Butte 
et al. 2003). Spearman correlation coeffi-
cients were calculated between PCB-153 
and GWG/FM and between GWG/FM and 
birth weight. We first estimated the associa-
tion between cord serum PCB-153 and birth 
weight using linear multivariate-adjusted 
regression models in each cohort separately, 
and then we used mixed-effect models to 
estimate the combined effect (pooled 
analysis). We included absolute GWG or 
estimated FM as additional potential 
confounders in the models. 
The absolute GWG and estimated FM 
distributions were relatively similar among 
cohorts (mean + SD was 13.9 ± 5.3 kg for 
GWG and 5.5 ± 4.5 kg for FM). We found 
low correlations between PCB-153 and 
GWG/FM and between GWG/FM and birth 
weight (r < 0.18). The effect estimate of the 
combined analysis yielded a negative asso-
ciation between PCB-153 and birth weight 
equivalent to a 293-g reduction [95% con-
fidence interval (CI): –536, –50] in birth 
weight per 1-µg/L increase in cord serum 
PCB-153. After including absolute GWG or 
estimated FM in the model, the strength of 
the association was reduced by 48% [–153 g 
(95% CI: –340, 30)] and 31% [–204 g 
(95% CI: –411, 0)], respectively.
Our reanalysis of earlier data with some 
new data confirms that GWG may indeed 
confound the relationship between PCB-153 
and birth weight; however, when we included 
in the model either absolute GWG or esti-
mated FM, which is a more precise estimate 
of maternal lipid gain (Butte et al. 2003), 
we still observed an important reduction in 
birth weight as PCB-153 levels increased. 
We cannot exclude the possibility of residual 
confounding due to potential measure ment 
error of GWG, which may further reduce 
the effect toward the null. However, two of 
the included cohorts showed high correla-
tions between measured and self-reported 
weight, suggesting that misclassification due 
to maternal weight reports is likely to be 
small and negligible. Misclassification could 
result from inaccurate assessment of FM. In 
a recent study, Maple-Brown et al. (2013) 
observed that maternal age and pre pregnancy 
body mass index can be related to an increase 
in gestational FM, suggesting that it is worth 
considering both of them in models assessing 
fat mass. 
As suggested by Verner et al. (2013), we 
have considered GWG as a potential con-
founder because it increases the volume of 
lipids diluting PCB levels in blood (Glynn 
et al. 2011) and increases birth weight of the 
offspring (Siega-Riz et al. 2009). However, 
other than a confounding factor, GWG 
could be an intermediate factor on a causal 
path between PCB-153 exposure and birth 
weight. If this is the case, then controlling 
for GWG in the models would lead to an 
over adjustment bias (Schisterman et al. 
2009) in the effect estimates and would be 
inappropriate if the main aim is to estimate 
the total (and not the direct) effect of 
PCB-153 on birth weight. 
In conclusion, in interpreting the 
findings by Verner et al. (2013) one should 
take into account that PBPK models, 
although useful, are based on many assump-
tions. The only way to verify them is through 
testing in population-based studies. Our 
analysis clearly indicates that attributing all 
the effect of PCBs on birth weight to GWG 
appears an oversimplification. 
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In our recent paper (Verner et al. 2013), 
we suggested that gestational weight 
gain (GWG) confounded the associa tion 
between pre natal PCB-153 (poly chlorinated 
A 90 volume 122 | number 4 | April 2014 • Environmental Health Perspectives
Correspondence
biphenyl-153) exposure and birth weight 
observed in the meta-analysis by Govarts 
et al. (2012). Govarts et al. have now per-
formed additional analyses in which they 
accounted for GWG in cohorts where this 
information could be abstracted from medi-
cal records or questionnaires. Their effort 
is comm endable and sheds light on results 
from both our paper and their meta-analysis. 
In line with our findings, they reported that 
adjusting for GWG in statistical models of 
PCB-153 and birth weight substantially 
reduced the strength of the association, 
without completely attenuating it. 
In Govarts et al.’s reanalysis, adjust-
ment for GWG resulted in a reduction in 
the association from a 293-g decrease [95% 
confidence interval (CI): –536, –50] in birth 
weight per 1-µg/L increase in cord serum 
PCB-153 to 153 g (95% CI: –340, 30), 
which represents a 48% reduction in the 
effect estimate. In comparison, our analyses 
using pharmacokinetic modeling suggested  
that 79% of the 150-g (95% CI: –240, –50) 
reduction in birth weight per 1-µg/L increase 
in cord serum PCB-153 reported in the 
original paper by Govarts et al. (2012) may 
be attributable to GWG. It is difficult to 
speculate how much more attenua tion of the 
PCB-153–birth weight association would 
occur if it were possible to accurately mea-
sure gain in fat mass during pregnancy—the 
underlying, true confounder—and adjust for 
it. The data presented by Butte et al. (2003) 
show that only 57.8% of the variability in 
the amount of fat mass gained in pregnancy 
is explained by GWG. Sensitivity analyses 
to assess the influence of such an improved 
adjustment would be of interest. 
In their letter, Govarts et al. touched 
on the assumptions of pharmaco kinetic 
models. Both meta-analyses of observational 
data (Greenland and O’Rourke 2008) and 
pharmaco kinetic simulations of epidemio-
logic associations have their strengths, and 
both can produce results that may appear 
more precise and conclusive than warranted. 
In those settings where both approaches can 
be applied, their results can be combined and 
used to make an improved inference about an 
association that neither method can defini-
tively quantify. The example of PCB-153 and 
birth weight in which confounding by GWG 
was revealed by pharmaco kinetic modeling 
and subsequently accounted for in statistical 
models demonstrates how these two comple-
mentary approaches can work hand in hand 
to generate more robust effect estimates.
Whether some causal (or perhaps any) 
association exists between environ mental 
PCB-153 exposure and birth weight is 
probably beyond the resolution of currently 
available or practicable methods.
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